KBC Group’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.58M | Sell |
191,837
-1,971
| -1% | -$36.7K | 0.01% | 500 |
|
2025
Q1 | $3.71M | Buy |
193,808
+1,329
| +0.7% | +$25.5K | 0.01% | 501 |
|
2024
Q4 | $6.93M | Buy |
192,479
+56,461
| +42% | +$2.03M | 0.02% | 436 |
|
2024
Q3 | $5.77M | Sell |
136,018
-103,396
| -43% | -$4.39M | 0.02% | 452 |
|
2024
Q2 | $9.65M | Sell |
239,414
-530
| -0.2% | -$21.4K | 0.03% | 343 |
|
2024
Q1 | $8.5M | Hold |
239,944
| – | – | 0.03% | 365 |
|
2023
Q4 | $7.1M | Buy |
239,944
+110,630
| +86% | +$3.27M | 0.03% | 406 |
|
2023
Q3 | $2.69M | Buy |
129,314
+61,940
| +92% | +$1.29M | 0.01% | 542 |
|
2023
Q2 | $1.65M | Sell |
67,374
-551
| -0.8% | -$13.5K | 0.01% | 625 |
|
2023
Q1 | $2.76M | Buy |
67,925
+5,276
| +8% | +$214K | 0.01% | 601 |
|
2022
Q4 | $2.82M | Buy |
62,649
+1,149
| +2% | +$51.6K | 0.01% | 542 |
|
2022
Q3 | $2.94M | Hold |
61,500
| – | – | 0.02% | 484 |
|
2022
Q2 | $3.64M | Sell |
61,500
-12,647
| -17% | -$749K | 0.02% | 450 |
|
2022
Q1 | $8.62M | Sell |
74,147
-15,705
| -17% | -$1.83M | 0.03% | 346 |
|
2021
Q4 | $13.5M | Buy |
89,852
+28,695
| +47% | +$4.32M | 0.04% | 308 |
|
2021
Q3 | $7.3M | Buy |
+61,157
| New | +$7.3M | 0.03% | 408 |
|